Skip to content
Clinical Trials – home

Centre Hospitalier Universitaire De Nantes

Verifiedinfo

France Boulevard Du Professeur Jacques Monod, 44800 Nantes, France

  • 300 trials recruiting
  • Non-small cell lung cancer · Crohn's disease · Plasma cell myeloma
  • Adults and children

About Specializations

Centre Hospitalier Universitaire De Nantes in Nantes, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Crohn's disease, Plasma cell myeloma, Acute myeloid leukaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Dermatology Clinical Research at Centre Hospitalier Universitaire De Nantes

The trial portfolio focuses on Skin and Connective Tissue Diseases, with research centered on atopic dermatitis and eczema. This work is aimed at improving care for people living with chronic inflammatory skin conditions.

  • Studies are evaluating new treatment approaches for moderate-to-severe atopic dermatitis.
  • Research is assessing whether adding a targeted therapy can improve symptom control compared with standard care.
  • The site contributes to pediatric and adolescent dermatology research, including studies in younger patients with eczema.

With 6 clinical trials and a large investigator base, the Nantes site supports active clinical testing in inflammatory skin disease, combining treatment evaluation with efforts to improve outcomes for patients and families.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Boulevard Du Professeur Jacques Monod44800 NantesFrance
Recruiting now
300 trials
Conditions studied
222
Partner status
Verified

More sites in NantesFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

1 048 clinical trials

Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC

Narcolepsy

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Alks 2680
  • Sponsor:Alkermes Inc.
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Lebrikizumab
  • Sponsor:Eli Lilly & Co.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.